A detailed history of Homestead Advisers Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Homestead Advisers Corp holds 924,846 shares of ABT stock, worth $107 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares
924,846
Previous 998,246 7.35%
Holding current value
$107 Million
Previous $104 Million 1.65%
% of portfolio
2.56%
Previous 2.57%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$100.07 - $118.13 $7.35 Million - $8.67 Million
-73,400 Reduced 7.35%
924,846 $105 Million
Q2 2024

Jul 23, 2024

SELL
$100.73 - $112.44 $1.63 Million - $1.82 Million
-16,200 Reduced 1.6%
998,246 $104 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $87,616 - $96,768
-800 Reduced 0.08%
1,014,446 $115 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $7.75 Million - $9.48 Million
-85,900 Reduced 7.8%
1,015,246 $112 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $14.4 Million - $17.3 Million
-151,089 Reduced 12.07%
1,101,146 $107 Million
Q2 2023

Jul 25, 2023

BUY
$100.78 - $112.29 $17.4 Million - $19.4 Million
172,789 Added 16.01%
1,252,235 $137 Million
Q1 2023

Apr 27, 2023

SELL
$96.86 - $114.01 $5.31 Million - $6.25 Million
-54,800 Reduced 4.83%
1,079,446 $109 Million
Q4 2022

Feb 03, 2023

SELL
$95.06 - $111.52 $3.23 Million - $3.79 Million
-34,000 Reduced 2.91%
1,134,246 $125 Million
Q3 2022

Nov 07, 2022

SELL
$96.76 - $112.03 $251,576 - $291,278
-2,600 Reduced 0.22%
1,168,246 $113 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $2.19 Million - $2.67 Million
-19,200 Reduced 1.61%
1,170,846 $139 Million
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $982,005 - $1.2 Million
-8,500 Reduced 0.71%
1,190,046 $167 Million
Q3 2021

Nov 05, 2021

SELL
$116.66 - $129.06 $4.55 Million - $5.03 Million
-39,000 Reduced 3.15%
1,198,546 $142 Million
Q2 2021

Aug 02, 2021

SELL
$105.79 - $124.53 $4.02 Million - $4.73 Million
-38,000 Reduced 2.98%
1,237,546 $143 Million
Q1 2021

May 07, 2021

SELL
$108.84 - $128.23 $6.76 Million - $7.96 Million
-62,100 Reduced 4.64%
1,275,546 $153 Million
Q4 2020

Feb 10, 2021

SELL
$105.0 - $114.42 $3.55 Million - $3.87 Million
-33,800 Reduced 2.46%
1,337,646 $146 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $12.7 Million - $15.4 Million
-138,200 Reduced 9.15%
1,371,446 $149 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $76,570 - $98,000
1,000 Added 0.07%
1,509,646 $138 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $2.68 Million - $3.92 Million
-42,719 Reduced 2.75%
1,508,646 $119 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $1.2 Million - $1.33 Million
-15,251 Reduced 0.97%
1,551,365 $135 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $4.29 Million - $4.65 Million
-52,384 Reduced 3.24%
1,566,616 $131 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $327,800 - $371,350
5,000 Added 0.31%
1,619,000 $117 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $77.6 Million - $86.6 Million
1,614,000
1,614,000 $86.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Homestead Advisers Corp Portfolio

Follow Homestead Advisers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.